Medisafe 1 Announces Interest from Becton, Dickenson and Company

Oxford, MS 4/5/2011 (Penny PayDay) -- Medisafe 1 Technologies (OTC:MFTH), a developer of patented technologies that physically prevent unauthorized administration of prescription medications, announced today, in a press release, that the multinational medical supplier, Becton, Dickenson and Company (“BD”) has expressed interest in learning more about Medisafe 1 Technologies' patented products and solutions for possible business collaboration. As I write, shares of Medisafe 1were flat at $0.189 per share on volume of 184,831 shares compared to its average daily volume of 203,873 shares. The company has a market cap of $10 million and a 52-week range between $0.11 and $0.45 per share.

BD manufactures and sells a broad range of medical supplies, devices, laboratory equipment and diagnostic products. BD is headquartered in the United States and has offices in more than 50 countries worldwide.

"Medisafe 1 continues to garner interest from leading firms in the healthcare industry," said Jacob Elhadad, CEO of Medisafe 1 Technologies. "We are pleased by the inquiries we have received, particularly from multinational corporations that are interested in potentially marketing and distributing our preventative solutions."

Medisafe 1 Technologies seeks to effectively prevent unauthorized administration of a drug or medicinal substance by hypodermic needle. Medisafe's patented technology is a medical assembly with a locking mechanism that is intended to ensure the substance cannot be released from the hypodermic needle without positive pre-matching between the substance and its intended patient.

DISCLAIMER: PennyPayDay.com has been compensated three thousand five hundred dollars for profile coverage of Medisafe 1 Technologies (MFTH) by a third party.

Distributed by IntelBuilder Social Media Platform